Cancer Research · 2013 · 184 citations · 30 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionAndrogen Deprivation TherapyCancer Cell SignalingCancer Stem Cell BiologyCancer Stem CellsProstate CancerSteroid Hormone SignalingAndrogen Deprivation Therapy ResistanceAndrogen Receptor ExpressionAndrogen Receptor TargetingCancer Stem Cell MarkersCancer Stem-like CellsProstate Stem Cell BiologyStat3 SignalingTumor Initiating Cells
Androgen receptor (AR) signaling is important for prostate cancer progression. However, androgen-deprivation and/or AR targeting-based therapies often lead to resistance. Here, we demonstrate that loss of AR expression results in STAT3 activation in prostate cancer cells. AR downregulation further leads to development of prostate cancer stem-like cells (CSC), which requires STAT3. In human prostate tumor tissues, elevated cancer stem-like cell markers coincide with those cells exhibiting high STAT3 activity and low AR expression. AR downregulation-induced STAT3 activation is mediated through increased interleukin (IL)-6 expression. Treating mice with soluble IL-6 receptor fusion protein or silencing STAT3 in tumor cells significantly reduced prostate tumor growth and CSCs. Together, these findings indicate an opposing role of AR and STAT3 in prostate CSC development.
30
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research · 2005 · 2.8K citations
Medicine, Cell Biology, Oncology +17
Jacqueline Bromberg, Melissa H Wrzeszczynska, Geeta Devgan et al. · Cell · 1999 · 2.8K citations · Full text